Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas

被引：0
|
作者：
Audrey Laroche-Clary
Vanessa Chaire
Marie-Paule Algeo
Marie-Alix Derieppe
François L. Loarer
Antoine Italiano
机构：
[1] Université de Bordeaux,Department of Medical Oncology
[2] Institut National de la Santé et de la Recherche Medicale (INSERM) U1218,undefined
[3] Institut Bergonié,undefined
[4] Institut Bergonié,undefined
来源：
Journal of Hematology & Oncology | / 10卷
关键词：
MDM2; CDK4; Well-differentiated/dedifferentiated liposarcomas;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
    Laroche-Clary, Audrey
    Chaire, Vanessa
    Algeo, Marie-Paule
    Derieppe, Marie-Alix
    Loarer, Francois L.
    Italiano, Antoine
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [2] Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
    Cassinelli, Giuliana
    Pasquali, Sandro
    Lanzi, Cinzia
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon
    Italiano, Antoine
    Bianchini, Laurence
    Keslair, Frederique
    Bonnafous, Stephanie
    Cardot-Leccia, Nathalie
    Coindre, Jean-Michel
    Dumollard, Jean-Marc
    Hofman, Paul
    Leroux, Agnes
    Mainguene, Claire
    Peyrottes, Isabelle
    Ranchere-Vince, Dominique
    Terrier, Philippe
    Tran, Albert
    Gual, Philippe
    Pedeutour, Florence
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2233 - 2241
  • [4] Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas:: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity
    Coindre, JM
    Hostein, I
    Maire, G
    Derré, J
    Guillou, L
    Leroux, A
    Ghnassia, JP
    Collin, F
    Pedeutour, F
    Aurias, A
    [J]. JOURNAL OF PATHOLOGY, 2004, 203 (03): : 822 - 830
  • [5] p16 Immunohistochemistry is Less Useful Than MDM2 and CDK4 to Distinguish Dedifferentiated Liposarcomas From Other Retroperitoneal Mimics
    Kang, Yuna
    Horvai, Andrew E.
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (01) : 58 - 63
  • [6] The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma
    Limbach, Abberly Lott
    Lingen, Mark W.
    McElherne, James
    Mashek, Heather
    Fitzpatrick, Carrie
    Hyjek, Elizabeth
    Mostofi, Reza
    Cipriani, Nicole A.
    [J]. HEAD & NECK PATHOLOGY, 2020, 14 (04): : 889 - 898
  • [7] The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma
    Abberly Lott Limbach
    Mark W. Lingen
    James McElherne
    Heather Mashek
    Carrie Fitzpatrick
    Elizabeth Hyjek
    Reza Mostofi
    Nicole A. Cipriani
    [J]. Head and Neck Pathology, 2020, 14 : 889 - 898
  • [8] MDM2 and CDK4 expression in periosteat osteosarcoma
    Righi, Alberto
    Gambarotti, Marco
    Benini, Stefania
    Gamberi, Gabriella
    Cocchi, Stefania
    Picci, Piero
    Bertoni, Franco
    [J]. HUMAN PATHOLOGY, 2015, 46 (04) : 549 - 553
  • [9] MDM2 and CDK4 as a therapeutic target in sarcomas
    Blay, J.
    Le Cesne, A.
    Cassier, P.
    Ray-Coquard, I.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S70 - S70
  • [10] Amplification of CDK4 and MDM2 in malignant melanoma
    Muthusamy, V
    Hobbs, C
    Nogueira, C
    Cordon-Cardo, C
    McKee, PH
    Chin, L
    Bosenberg, MW
    [J]. GENES CHROMOSOMES & CANCER, 2006, 45 (05): : 447 - 454
12345